Update on Anti-Vascular Endothelial Growth Factor Safety for Retinopathy of Prematurity.

Asia-Pacific Journal of Ophthalmology
Ana Bety EnríquezCaroline R Baumal

Abstract

Retinopathy of prematurity (ROP) is a neovascular retinal disorder that occurs in infants born prematurely. Nowadays, ROP constitutes a leading cause of childhood blindness worldwide and for decades the standard of care has involved peripheral retinal ablation. However, this type of treatment requires the use of specialized equipment by well-trained physicians, has been associated with poor structural and visual outcomes in some preterm infants, and despite its adequate application, some cases of ROP may continue to progress. Therefore, the need for simpler and more efficient strategies made anti-vascular endothelial growth factor (anti-VEGF) medications an appealing option for treatment. Recently, the use of anti-VEGF agents for ROP has increased worldwide; nevertheless, this practice remains off-label, and there is a lack of information regarding its safety profile and the possibility of unfavorable long-term outcomes causes the utmost concern. This review updates the recent evidence regarding the systemic and ocular safety of anti-VEGF treatment for ROP.

References

Sep 12, 2007·Archives of Ophthalmology·Monte D Mills
Jul 19, 2008·American Journal of Ophthalmology·Tim U KrohneCarsten H Meyer
Aug 19, 2008·Investigative Ophthalmology & Visual Science·Lois E H Smith
Jun 29, 2010·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Hossein NazariKhalil Ghasemi Falavarjani
Nov 3, 2010·Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus·Sun Young JangSung Jin Lee
Feb 18, 2011·The New England Journal of Medicine·Helen A Mintz-HittnerUNKNOWN BEAT-ROP Cooperative Group
Mar 2, 2011·Investigative Ophthalmology & Visual Science·Gerard A LuttyStanley J Wiegand
May 23, 2012·Archives of Disease in Childhood. Fetal and Neonatal Edition·Parag K ShahNarendran Kalpana
Jul 24, 2012·American Journal of Ophthalmology·Tim U KrohneCarsten H Meyer
Feb 20, 2014·Investigative Ophthalmology & Visual Science·Clayton C TokunagaKimberly A Drenser
Mar 13, 2014·Indian Journal of Ophthalmology·Gaurav SanghiAmod Gupta
Dec 17, 2014·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Huseyin YetikZiya Salihoglu
Jan 24, 2015·Investigative Ophthalmology & Visual Science·Lingkun KongPaul G Steinkuller
Mar 24, 2015·Journal of Pediatric Ophthalmology and Strabismus·Michael A Klufas, R V Paul Chan
Apr 9, 2015·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Ying ZhouLi Chen
Dec 18, 2015·Arquivos brasileiros de oftalmologia·Muhammet Kazim ErolZuhal Ozen Tunay
Feb 11, 2016·World Journal of Clinical Pediatrics·Parag K ShahNarendran Kalpana
Mar 10, 2016·Seminars in Ophthalmology·Luai Eldweik, Iason S Mantagos
Mar 25, 2016·Acta Ophthalmologica·Reza KarkhanehHamidreza Torabi
May 18, 2016·Ophthalmic Surgery, Lasers & Imaging Retina·Kirstin L TawseCaroline R Baumal
Jun 1, 2016·Pediatrics·Julie MorinUNKNOWN Canadian Neonatal Network and the Canadian Neonatal Follow-Up Network Investigators
Jun 1, 2016·Pediatrics·Graham E Quinn, Brian A Darlow

❮ Previous
Next ❯

Citations

Mar 6, 2021·Survey of Ophthalmology·Hao TanJohn Peter Campbell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Archivos de la Sociedad Española de Oftalmología
I González ViejoV Pueyo Royo
Asia-Pacific Journal of Ophthalmology
Kimberly D TranAudina M Berrocal
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus
David K Wallace
© 2021 Meta ULC. All rights reserved